Table 3.
Variable |
Survival status |
Total | CHR, (95%CI) | AHR, (95% CI) | |
---|---|---|---|---|---|
Event (TB) | Censored | ||||
Sex |
|
|
|
|
|
Male |
64 |
115 |
179 |
1.58 (1.13-2.22) |
1.4 (0.99-1.98) |
Female |
72 |
219 |
291 |
1.00 |
1.00 |
Tobacco use |
|
|
|
|
|
Yes |
18 |
26 |
44 |
1.64(1.00-2.70) |
1.46(0.85-2.49) |
No |
118 |
306 |
424 |
1.00 |
1.00 |
Functional status |
|
|
|
|
|
Working |
79 |
263 |
342 |
1.00 |
|
Ambulatory/Bed ridden |
57 |
71 |
128 |
2.27(1.61 3.19) |
1.64(1.13-2.38) |
WHO clinical stage |
|
|
|
|
|
I/II |
91 |
11 |
102 |
|
1.00 |
III |
202 |
92 |
294 |
3.26(1.74 ,6.10) |
2.88(1.53-5.43) |
IV |
41 |
33 |
74 |
5.55(2.80, 0.99) |
3.82(1.86-7.85) |
CD4 cell count |
|
|
|
|
|
<50 |
41 |
36 |
77 |
2.61(1.58-4.30) |
2.13(1.28-3.53) |
50-200 |
196 |
73 |
269 |
1.28(0.82,1.99) |
1.27(0.81-1.98) |
>200 | 97 | 27 | 124 | 1.00 | 1.00 |